1. Dennis EA (maio de 1994). "Diversity of group types, regulation, and function of phospholipase A2". The Journal of Biological Chemistry. 269 (18): 13057–60. PMID 8175726.
Nicolas JP, Lin Y, Lambeau G, Ghomashchi F, Lazdunski M, Gelb MH (março de 1997). "Localization of structural elements of bee venom phospholipase A2 involved in N-type receptor binding and neurotoxicity". The Journal of Biological Chemistry. 272 (11): 7173–81. doi:10.1074/jbc.272.11.7173. PMID 9054413.
Argiolas A, Pisano JJ (novembro de 1983). "Facilitation of phospholipase A2 activity by mastoparans, a new class of mast cell degranulating peptides from wasp venom". The Journal of Biological Chemistry. 258 (22): 13697–702. PMID 6643447.
PDB: 1FXF; Pan YH, Epstein TM, Jain MK, Bahnson BJ (janeiro de 2001). "Five coplanar anion binding sites on one face of phospholipase A2: relationship to interface binding". Biochemistry. 40 (3): 609–17. doi:10.1021/bi002514g. PMID 11170377.
PDB: 1FXF; Pan YH, Epstein TM, Jain MK, Bahnson BJ (January 2001). "Five coplanar anion binding sites on one face of phospholipase A2: relationship to interface binding". Biochemistry. 40 (3): 609–17. doi:10.1021/bi002514g. PMID 11170377.
Leslie CC (julho de 1997). "Properties and regulation of cytosolic phospholipase A2". The Journal of Biological Chemistry. 272 (27): 16709–12. doi:10.1074/jbc.272.27.16709. PMID 9201969.
Farooqui AA, Ong WY, Horrocks LA (setembro de 2006). "Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders". Pharmacological Reviews. 58 (3): 591–620. doi:10.1124/pr.58.3.7. PMID 16968951.
Bell JG, MacKinlay EE, Dick JR, MacDonald DJ, Boyle RM, Glen AC (outubro de 2004). "Essential fatty acids and phospholipase A2 in autistic spectrum disorders". Prostaglandins, Leukotrienes, and Essential Fatty Acids. 71 (4): 201–4. doi:10.1016/j.plefa.2004.03.008. PMID 15301788.
